Keywords: allergan, patent, court, ruling, removes, incentives, misuses
Allergan patent court ruling "removes R&D incentives, misuses Hatch-Waxman"
Article | 10 November 2003
The Washington Legal Foundation has called on the US Supreme Court toreview an appeals court decision that denies a pharmaceutical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
